Search Login Register

Anti-Arrhythmia Agents Summary

Description: Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.

Also Known As: Anti-Arrhythmia Drugs; Anti-Arrhythmics; Antiarrhythmia Agents; Antiarrhythmia Drugs; Antiarrhythmic Drugs Show All >>

Networked: 1964 relevant articles (175 outcomes, 241 trials/studies) for this Bio-Agent

Key Diseases for which Anti-Arrhythmia Agents is Relevant

  1. Atrial Fibrillation : 58 outcomes 59 studies in 412 results
  2. Cardiac Arrhythmias (Arrythmia) : 34 outcomes 57 studies in 373 results
  3. Ventricular Tachycardia : 30 outcomes 27 studies in 264 results
  4. Tachycardia (Tachyarrhythmias) : 29 outcomes 25 studies in 263 results
  5. Ventricular Fibrillation : 9 outcomes 12 studies in 87 results
Show All >>

Drugs Related to Anti-Arrhythmia Agents

  1. Amiodarone (Amiodarona)
  2. Ion Channels (Ion Channel)
  3. Flecainide (Tambocor)
  4. Lidocaine (Xylocaine)
  5. Sotalol (Sotalol Hydrochloride)
  6. Disopyramide (Norpace)
  7. Calcium
  8. Encainide
  9. Quinidine (Chinidin)
  10. Bepridil (Vascor)
Show All >>

Therapies Related to Anti-Arrhythmia Agents

  1. Electric Countershock (Cardioversion)
  2. Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
  3. Drug Therapy (Chemotherapy)
  4. Ligation
  5. Defibrillators (Defibrillator)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.